The Novartis Institute for Tropical Diseases (NITD) represents a major part of Novartis' bid to improve the developing world's access to medicines. The NITD's overarching goal is to discover novel treatments and prevention methods for major tropical diseases. In those developing countries where these diseases are endemic, the Novartis Group intends to make treatments readily available without profit.
The focus of this institute is to apply Novartis' drug-discovery expertise and cutting-edge technology platforms to fight against infectious diseases that are currently not well covered by modern treatment regimens, particularly dengue fever and tuberculosis. The scope of activities range from target discovery through to screen development and compound optimisation.
| 
